Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage

Audiology and Neuro-Otology

Volumn 9, Issue 3, 2004, Pages 135-143

  Nakaizumi, Toshihiko ^a   Kawamoto, Kohei ^a   Minoda, Ryosei ^a   Raphael, Yehoash ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Brain derived neurotrophic factor; Ciliary derived neurotrophic factor; Gene therapy; Spiral ganglion

Indexed keywords

ADENOVIRUS VECTOR; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; RECOMBINANT CILIARY NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY BRAIN STEM IMPLANT; CELL COUNT; CELL SURVIVAL; COCHLEA; COCHLEA FENESTRA; CONTROLLED STUDY; HAIR CELL; HEARING IMPAIRMENT; NEUROPROTECTION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; SPIRAL GANGLION; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CILIARY NEUROTROPHIC FACTOR; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GUINEA PIGS; HAIR CELLS; HEARING LOSS, SENSORINEURAL; NERVE DEGENERATION; NEURONS, AFFERENT; SPIRAL GANGLION;

EID: 1842729373     PISSN: 14203030     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077264     Document Type: Article

References (84)

1. Agerman K, Canlon B, Duan M, Ernfors P: Neurotrophins, NMDA receptors, and nitric oxide in development and protection of the auditory system. Ann NY Acad Sci 1999;884:131-142.
2. Aitkin LM, Nelson JE, Shepherd RK: Hearing, vocalization and the external ear of a marsupial, the northern quoll, Dasyurus hallucatus. J Comp Neurol 1994;349:377-388.
3. Alonzi T, Middleton G, Wyatt S, Buchman V, Betz UA, Muller W, Musiani P, Poli V, Davies AM: Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Mol Cell Neurosci 2001;18:270-282.
4. Altschuler RA, Cho Y, Ylikoski J, Pirvola U, Magal E, Miller JM: Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann NY Acad Sci 1999;884:305-311.
5. Balicki D, Beutler E: Gene therapy of human disease. Medicine (Baltimore) 2002;81:69-86.
6. Baumgartner BJ, Shine HD: Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci 1997;17:6504-6511.
7. Bazan JF: Neuropoietic cytokines in the hematopoietic fold. Neuron 1991;7:197-208.
8. Bowers WJ, Chen X, Guo H, Frisina DR, Federoff HJ, Frisina RD: Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol Ther 2002;6:12-18.
9. Burek MJ, Oppenheim RW: Programmed cell death in the developing nervous system. Brain Pathol 1996;6:427-446.
10. Chen AH, Mueller RF, Prasad SD, Greinwald JH Jr, Manaligod J, Muilenburg AC, Verhoeven K, Van Camp G, Smith RJ: Presymptomatic diagnosis of nonsyndromic hearing loss by genotyping. Arch Otolaryngol Head Neck Surg 1998;124:20-24.
11. Clopton BM, Spelman FA, Miller JM: Estimates of essential neural elements for stimulation through a cochlear prosthesis. Ann Otol Rhinol Laryngol Suppl 1980;89:5-7.
12. Despres G, Leger GP, Dahl D, Romand R: Distribution of cytoskeletal proteins (neurofilaments, peripherin and MAP-tau) in the cochlea of the human fetus. Acta Otolaryngol 1994;114:377-381.
13. Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ: Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci USA 1998;95:3978-3983.
14. Dodson HC, Mohuiddin A: Response of spiral ganglion neurones to cochlear hair cell destruction in the guinea pig. J Neurocytol 2000;29:525-537.
15. Dolcet X, Soler RM, Gould TW, Egea J, Oppenheim RW, Comella JX: Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway. Mol Cell Neurosci 2001;18:619-631.
16. Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR, Lassi NK: Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 1997;30:347-374.
17. Ernfors P, Duan ML, El Shamy WM, Canlon B: Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 1996;2:463-467.
18. Ernfors P, Lee KF, Jaenisch R: Target derived and putative local actions of neurotrophins in the peripheral nervous system. Prog Brain Res 1994;103:43-54.
19. Ernfors P, Merlio JP, Persson H: Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur J Neurosci 1992;4:1140-1158.
20. Ernfors P, Van de Water T, Loring J, Jaenisch R: Complementary roles of BDNF and NT-3 in vestibular and auditory development (published erratum appears in Neuron 1995;15:739). Neuron 1995;14:1153-1164.
21. Evans DE, Niparko JK, Miller JM, Jyung RW, Anderson DJ: Multiple-channel stimulation of the cochlear nucleus. Otolaryngol Head Neck Surg 1989;101:651-657.
22. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF: Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994;369:658-661.
23. Fayad J, Linthicum FH Jr, Otto SR, Galey FR, House WF: Cochlear implants: Histopathologic findings related to performance in 16 human temporal bones. Ann Otol Rhinol Laryngol 1991;100:807-811.
24. Frank DA, Greenberg ME: Signal transduction pathways activated by ciliary neurotrophic factor and related cytokines. Perspect Dev Neurobiol 1996;4:3-18.
25. Fritzsch B, Barbacid M, Silos-Santiago I: The combined effects of trkB and trkC mutations on the innervation of the inner ear. Int J Dev Neurosci 1998;16:493-505.
26. Fritzsch B, Pirvola U, Ylikoski J: Making and breaking the innervation of the ear: Neurotrophic support during ear development and its clinical implications. Cell Tissue Res 1999;295:369-382.
27. Fritzsch B, Silos-Santiago I, Bianchi LM, Farinas I: The role of neurotrophic factors in regulating the development of inner ear innervation. Trends Neurosci 1997;20:159-164.
28. Gao WQ: Role of neurotrophins and lectins in prevention of ototoxicity. Ann NY Acad Sci 1999;884:312-327.
29. Ghorayer B, Sarwat A, Linthicum FH Jr: Viable spiral ganglion cells in congenital and acquired profound hearing loss. J Laryngol Otol 1980;94:367-376.
30. Hansen MR, Zha XM, Bok J, Green SH: Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro. J Neurosci 2001;21:2256-2267.
31. Hartnick CJ, Staecker H, Malgrange B, Lefebvre PP, Liu W, Moonen G, Van de Water TR: Neurotrophic effects of BDNF and CNTF, alone and in combination, on postnatal day 5 rat acoustic ganglion neurons. J Neurobiol 1996;30:246-254.
32. 2+]i within a set range. J Neurosci 1997;17:1959-1970.
33. Hinojosa R, Lindsay JR: Profound deafness: Associated sensory and neural degeneration. Arch Otolaryngol 1980;106:193-209.
34. Hsich G, Sena-Esteves M, Breakefield XO: Critical issues in gene therapy for neurologic disease. Hum Gene Ther 2002;13:579-604.
35. Ip NY, Li YP, van de Stadt I, Panayotatos N, Alderson RF, Lindsay RM: Ciliary neurotrophic factor enhances neuronal survival in embryonic rat hippocampal cultures. J Neurosci 1991;11:3124-3134.
36. Ip NY, Wiegand SJ, Morse J, Rudge JS: Injury-induced regulation of ciliary neurotrophic factor mRNA in the adult rat brain. Eur J Neurosci 1993;5:25-33.
37. Jyung RW, Miller JM, Cannon SC: Evaluation of eighth nerve integrity by the electrically evoked middle latency response. Otolaryngol Head Neck Surg 1989;101:670-682.
38. Kanzaki S, Kawamoto K, Oh SH, Stover T, Suzuki M, Ishimoto S, Yagi M, Miller JM, Lomax MI, Raphael Y: From gene identification to gene therapy. Audiol Neurootol 2002a;7:161-164.
39. Kanzaki S, Stover T, Kawamoto K, Prieskorn DM, Altschuler RA, Miller JM, Raphael Y: Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 2002b;454:350-360.
40. Kawamoto K, Ishimoto S, Minoda R, Brough DE, Raphael Y: Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003;23:4395-4400.
41. Kerr A, Schuknecht HF: The spiral ganglion in profound deafness. Acta Otolaryngol 1968;65:586-598.
42. Lalwani AK, Han JJ, Walsh BJ, Zolotukhin S, Muzyczka N, Mhatre AN: Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res 1997;114:139-147.
43. Leake PA, Hradek GT: Cochlear pathology of long term neomycin induced deafness in cats. Hear Res 1988;33:11-33.
44. Leake PA, Hradek GT, Rebscher SJ, Snyder RL: Chronic intracochlear electrical stimulation induces selective survival of spiral ganglion neurons in neonatally deafened cats. Hear Res 1991;54:251-271.
45. Leake PA, Hradek GT, Snyder RL: Chronic electrical stimulation by a cochlear implant promotes survival of spiral ganglion neurons after neonatal deafness. J Comp Neurol 1999;412:543-562.
46. Lefebvre PP, Malgrange B, Staecker H, Moghadass M, Van de Water TR, Moonen G: Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport 1994;5:865-868.
47. Li L, Parkins CW, Webster DB: Does electrical stimulation of deaf cochleae prevent spiral ganglion degeneration? Hear Res 1999;133:27-39.
48. Linthicum FH Jr, Anderson W: Cochlear implantation of totally deaf ears: Histologic evaluation of candidacy. Acta Otolaryngol 1991;111:327-331.
49. Linthicum FH Jr, Fayad J, Otto SR, Galey FR, House WF: Cochlear implant histopathology. Am J Otol 1991;12:245-311.
50. Liu X, Ernfors P, Wu H, Jaenisch R: Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature 1995;375:238-241.
51. Lo DC: A central role for ciliary neurotrophic factor? Proc Natl Acad Sci USA 1993;90:2557-2558.
52. Malgrange B, Rogister B, Lefebvre PP, Mazy-Servais C, Welcher AA, Bonnet C, Hsu RY, Rigo JM, Van de Water TR, Moonen G: Expression of growth factors and their receptors in the postnatal rat cochlea. Neurochem Res 1998;23:1133-1138.
53. Mattson MP: Neuroprotective Signal Transduction. Towtowa, Humana Press, 1998.
54. Miller AL: Effects of chronic stimulation on auditory nerve survival in ototoxically deafened animals. Hear Res 2001;151:1-14.
55. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA: Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997;15:631-643.
56. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM: Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994;265:1107-1110.
57. Nadol JB Jr: Patterns of neural degeneration in the human cochlea and auditory nerve: Implications for cochlear implantation. Otolaryngol Head Neck Surg 1997;117:220-228.
58. Nadol JB Jr, Burgess BJ, Reisser C: Morphometric analysis of normal human spiral ganglion cells. Ann Otol Rhinol Laryngol 1990;99:340-348.
59. Nadol JB Jr, Xu WZ: Diameter of the cochlear nerve in deaf humans: Implications for cochlear implantation. Ann Otol Rhinol Laryngol 1992;101:988-993.
60. Ogilvie JM, Speck JD, Lett JM: Growth factors in combination, but not individually, rescue rd mouse photoreceptors in organ culture. Exp Neurol 2000;161:676-685.
61. Otte J, Schunknecht HF, Kerr AG: Ganglion cell populations in normal and pathological human cochleae: Implications for cochlear implantation. Laryngoscope 1978;88:1231-1246.
62. Pirvola U, Arumae U, Moshnyakov M, Palgi J, Saarma M, Ylikoski J: Coordinated expression and function of neurotrophins and their receptors in the rat inner ear during target innervation. Hear Res 1994;75:131-144.
63. Pirvola U, Hallbook F, Xing-Qun L, Virkkala J, Saarma M, Ylikoski J: Expression of neurotrophins and Trk receptors in the developing, adult, and regenerating avian cochlea. J Neurobiol 1997;33:1019-1033.
64. Pirvola U, Ylikoski J, Palgi J, Lehtonen E, Arumae U, Saarma M: Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc Natl Acad Sci USA 1992;89:9915-9919.
65. Pujol R, Puel JL: Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: A review of recent findings. Ann NY Acad Sci 1999;884:249-254.
66. Schecterson LC, Bothwell M: Neurotrophin and neurotrophin receptor mRNA expression in developing inner ear. Hear Res 1994;73:92-100.
67. Schweizer U, Gunnersen J, Karch C, Wiese S, Holtmann B, Takeda K, Akira S, Sendtner M: Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J Cell Biol 2002;156:287-297.
68. Shah SB, Gladstone HB, Williams H, Hradek GT, Schindler RA: An extended study: Protective effects of nerve growth factor in neomycin-induced auditory neural degeneration. Am J Otol 1995;16:310-314.
69. Shinohara T, Bredberg G, Ulfendahl M, Pyykko I, Olivius NP, Kaksonen R, Lindstrom B, Altschuler R, Miller JM: Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci USA 2002;99:1657-1660.
70. Spoendlin H: Degeneration behaviour of the cochlear nerve. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1971;200:275-291.
71. Spoendlin H: Neuroanatomical basis of cochlear coding mechanisms. Audiology 1975;14:383-407.
72. Staecker H, Gabaizadeh R, Federoff H, Van de Water TR: Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 1998;119:7-13.
73. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR: NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996;7:889-894.
74. Stover T, Yagi M, Raphael Y: Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 2000;7:377-383.
75. Sutton D: Cochlear implant effects on the spiral ganglion. Ann Otol Rhinol Laryngol 1983;92:316.
76. Suzuki M, Yagi M, Brown JN, Miller AL, Miller JM, Raphael Y: Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther 2000;7:1046-1054.
77. Terenghi G: Peripheral nerve regeneration and neurotrophic factors. J Anat 1999;194:1-14.
78. Thorne M, Salt AN, De Mott JE, Henson MM, Henson OW Jr, Gewalt SL: Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images. Laryngoscope 1999;109:1661-1668.
79. Webster M, Webster DB: Spiral ganglion neuron loss following organ of Corti loss: A quantitative study. Brain Res 1981;212:17-30.
80. West BA, Brummett RE, Himes DL: Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch Otolaryngol 1973;98:32-37.
81. Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y: Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000;1:315-325.
82. Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, Altschuler R, Miller JM, Saarma M: Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998;124:17-26.
83. Zappia JJ, Altschuler RA: Evaluation of the effect of ototopical neomycin on spiral ganglion cell density in the guinea pig. Hear Res 1989;40:29-37.
84. Zheng JL, Stewart RR, Gao WQ: Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity. J Neurosci 1995;15:5079-5087.